Authors:
Laczika, K
Mitterbauer, G
Mitterbauer, M
Knobl, P
Schwarzinger, I
Greinix, HT
Rabitsch, W
Fonatsch, C
Mannhalter, C
Lechner, K
Jaeger, U
Citation: K. Laczika et al., Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBF beta/MYH11 RT-PCR: Implications for a monitoring schedule and for treatment decisions, LEUK LYMPH, 42(5), 2001, pp. 923-931
Authors:
Mitterbauer, M
Neumeister, P
Kalhs, P
Brugger, S
Fischer, C
Dieckmann, K
Hoecker, P
Hinterberger, W
Linkesch, W
Simonitsch, I
Jaeger, U
Lechner, K
Mannhalter, C
Mitterbauer, G
Greinix, HT
Citation: M. Mitterbauer et al., Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma, LEUKEMIA, 15(4), 2001, pp. 635-641
Authors:
Jordan, JH
Fritsche-Polanz, R
Sperr, WR
Mitterbauer, G
Fodinger, M
Schernthaner, GH
Bankl, HC
Gebhart, W
Chott, A
Lechner, K
Valent, P
Citation: Jh. Jordan et al., A case of 'smouldering' mastocytosis with high mast cell burden, monoclonal myeloid cells, and C-KIT mutation Asp-816-Val, LEUK RES, 25(7), 2001, pp. 627-634
Authors:
Keil, F
Mitterbauer, G
Chen, X
Haas, OA
Kalhs, P
Lechner, K
Mannhalter, C
Moser, K
Worel, N
Pirc-Danoewinata, H
Louda, N
Loidolt, H
Rabitsch, W
Greinix, HT
Citation: F. Keil et al., PBPC mobilization with chemotherapy and G-CSF in patients with chronic myeloid leukemia: quantification of bcr/abl-positive cells by interphase fluorescence in situ hybridization and competitive PCR, TRANSFUSION, 41(1), 2001, pp. 111-116
Authors:
Welzel, N
Le, T
Marculescu, R
Mitterbauer, G
Chott, A
Pott, C
Kneba, M
Du, MQ
Kusec, R
Drach, J
Raderer, M
Mannhalter, C
Lechner, K
Nadel, B
Jaeger, U
Citation: N. Welzel et al., Templated nucleotide addition and immunoglobulin J(H)-gene utilization in t(11;14) junctions: Implications for the mechanism of translocation and theorigin of mantle cell lymphoma, CANCER RES, 61(4), 2001, pp. 1629-1636
Citation: C. Mannhalter et al., Evaluation of RNA isolation methods and reference genes for RT-PCR analyses of rare target RNA, CLIN CH L M, 38(2), 2000, pp. 171-177
Authors:
Mitterbauer, M
Laczika, K
Novak, M
Mitterbauer, G
Hilgarth, B
Pirc-Danoewinata, H
Schwarzinger, I
Haas, OA
Fonatsch, C
Lechner, K
Jaeger, U
Citation: M. Mitterbauer et al., High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia - A single center study, AM J CLIN P, 113(3), 2000, pp. 406-410
Authors:
Reiter, E
Rabitsch, W
Greinix, HT
Keil, F
Mitterbauer, G
Hinterberger, W
Haas, OA
Lechner, K
Kalhs, P
Citation: E. Reiter et al., Relapse of chronic myelogenous leukemia 12 years after allogeneic marrow transplantation: Successful second transplantation with allogeneic peripheral blood progenitor cells, LEUK LYMPH, 40(1-2), 2000, pp. 215-218
Authors:
Laczika, K
Mitterbauer, G
Weltermann, A
Knobl, P
Thalhammer-Scherrer, R
Haas, OA
Lechner, K
Jaeger, U
Citation: K. Laczika et al., Prolonged third remission in a patient with acute promyelocytic leukemia after consolidation chemotherapy with intermittent intermediate dose Ara-C and maintenance with intermittent all-trans retinoic acid (ATRA), LEUK LYMPH, 36(5-6), 2000, pp. 625-629
Authors:
Reiter, E
Greinix, H
Rabitsch, W
Keil, F
Schwarzinger, I
Jaeger, U
Lechner, K
Worel, N
Streubel, B
Fonatsch, C
Mitterbauer, G
Kalhs, P
Citation: E. Reiter et al., Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversion inv (3)(q-21q26) or homologous translocation t(3;3) (q21;q26), ANN HEMATOL, 79(7), 2000, pp. 374-377
Authors:
Exner, M
Thalhammer, R
Kapiotis, S
Mitterbauer, G
Knobl, P
Haas, OA
Jager, U
Schwarzinger, I
Citation: M. Exner et al., The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): Does it prove true for the M3-variant?, CYTOMETRY, 42(2), 2000, pp. 106-109
Authors:
Edelhauser, M
Raber, W
Mitterbauer, G
Mannhalter, C
Lechner, K
Fonatsch, C
Citation: M. Edelhauser et al., Variant intra Philadelphia translocation with rearrangement of BCR-ABL andABL-BCR within the same chromosome in a patient with cALL, CANC GENET, 122(2), 2000, pp. 83-86
Authors:
Endler, G
Lalouschek, W
Exner, M
Mitterbauer, G
Haring, D
Mannhalter, C
Citation: G. Endler et al., The 4G/4G genotype at nucleotide position-675 in the promotor region of the plasminogen activator inhibitor 1 (PAI-1) gene is less frequent in young patients with minor stroke than in controls, BR J HAEM, 110(2), 2000, pp. 469-471
Authors:
Mitterbauer, G
Zimmer, C
Pirc-Danoewinata, H
Haas, OA
Hojas, S
Schwarzinger, I
Greinix, H
Jager, U
Lechner, K
Mannhalter, C
Citation: G. Mitterbauer et al., Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction, BR J HAEM, 109(3), 2000, pp. 622-628
Authors:
Jager, U
Bocskor, S
Le, T
Mitterbauer, G
Bolz, I
Chott, A
Kneba, M
Mannhalter, C
Nadel, B
Citation: U. Jager et al., Follicular lymphomas' BCL-2/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t(14;18) translocation, BLOOD, 95(11), 2000, pp. 3520-3529
Authors:
Mitterbauer, G
Winkler, K
Gisslinger, H
Geissler, K
Lechner, K
Mannhalter, C
Citation: G. Mitterbauer et al., Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (HUMARA) - Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosis, AM J CLIN P, 112(1), 1999, pp. 93-100
Authors:
Fiegl, M
Mitterbauer, G
Weltermann, A
Pirc-Danoewinata, H
Jager, U
Citation: M. Fiegl et al., Chronic myelogenous leukemia in chronic phase for 16 years: Ongoing hematological remission and late minor cytogenetic response under minimal interferon maintenance therapy, LEUK LYMPH, 35(3-4), 1999, pp. 409-413
Authors:
Agis, H
Weltermann, A
Mitterbauer, G
Thalhammer, R
Edelhauser, M
Seewann, HL
Valent, P
Lechner, K
Fonatsch, C
Geissler, K
Citation: H. Agis et al., Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia, ANN HEMATOL, 78(7), 1999, pp. 329-332
Authors:
Thalhammer-Scherrer, R
Wieselthaler, G
Knoebl, P
Schwarzinger, I
Simonitsch, I
Mitterbauer, G
Berlakovich, GA
Mannhalter, C
Haas, OA
Mayer, G
Muehlbacher, F
Wolner, E
Klepetko, W
Lechner, K
Jaeger, U
Citation: R. Thalhammer-scherrer et al., Post-transplant acute myeloid leukemia (PT-AML), LEUKEMIA, 13(3), 1999, pp. 321-326
Authors:
Mitterbauer, G
Zimmer, C
Fonatsch, C
Haas, OA
Thalhammer-Scherrer, R
Schwarzinger, I
Kahls, P
Jaeger, U
Lechner, K
Mannhalter, C
Citation: G. Mitterbauer et al., Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR, LEUKEMIA, 13(10), 1999, pp. 1519-1524
Authors:
Endler, G
Greinix, H
Winkler, K
Mitterbauer, G
Mannhalter, C
Citation: G. Endler et al., Genetic fingerprinting in mouthwashes of patients after allogeneic bone marrow transplantation, BONE MAR TR, 24(1), 1999, pp. 95-98
Authors:
Mitterbauer, G
Nemeth, P
Wacha, S
Cross, NCP
Schwarzinger, I
Jaeger, U
Geissler, K
Greinix, HT
Kalhs, P
Lechner, K
Mannhalter, C
Citation: G. Mitterbauer et al., Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction, BR J HAEM, 106(3), 1999, pp. 634-643